Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Medical Oncology

• Publication date

  2017-03-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-017-0935-0PMID 28364269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer statistics, 2019

  2019cited by this paper
• Doctor, Now That My Chemotherapy Treatment Is Over, When Will My "Chemofog" Lift?

  2017cited by this paper
• Breast cancer

  2017cited by this paper
• Adjuvant ovarian function suppression and cognitive function in women with breast cancer

  2016cited by this paper
• Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

  2016cited by this paper
• Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies

  2016cited by this paper
• Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study.

  2016cited by this paper
• Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.

  2016cited by this paper
• Objectively measured physical activity and cognitive functioning in breast cancer survivors

  2015cited by this paper
• A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy

  2015cited by this paper
• Decision-making impairments in breast cancer patients treated with tamoxifen.

  2014cited by this paper
• The effect of aromatase inhibition on the cognitive function of older patients with breast cancer.

  2014cited by this paper
• Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions

  2013cited by this paper
• Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

  2012cited by this paper
• Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

  2012cited by this paper
• Effects of adjuvant treatment on cognitive function in women with early breast cancer.

  2012cited by this paper
• An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

  2011cited by this paper
• A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients

  2011cited by this paper
• Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.

  2010cited by this paper
• Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial.

  2010cited by this paper
• Benefits and adverse effects of endocrine therapy.

  2010cited by this paper
• Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.

  2010cited by this paper
• Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

  2010cited by this paper
• The Vote of Acute Medical Inpatients

  2009cited by this paper
• Cognitive functioning in breast cancer survivors: A controlled comparison

  2009cited by this paper
• Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study

  2009cited by this paper
• Predictors of Cognitive Decline After Chemotherapy in Breast Cancer Patients

  2009cited by this paper
• Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients

  2008cited by this paper
• Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

  2008cited by this paper
• The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study

  2008cited by this paper
• Cognitive function during neoadjuvant chemotherapy for breast cancer

  2007cited by this paper
• Cognitive impairment associated with adjuvant therapy in breast cancer

  2006cited by this paper
• Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study

  2006influential reference
• Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.

  2006cited by this paper
• A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer

  2006cited by this paper
• A Meta-Analysis of the Neuropsychological Effects of Adjuvant Chemotherapy Treatment in Women Treated for Breast Cancer

  2006cited by this paper
• Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early‐stage breast carcinoma

  2005cited by this paper
• The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

  2005cited by this paper
• The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

  2005cited by this paper
• The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

  2004cited by this paper
• The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma

  2004cited by this paper
• Estrogen- and tamoxifen-associated effects on brain structure and function

  2004cited by this paper
• The effects of hormone therapy on cognition in breast cancer.

  2003cited by this paper
• Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

  2002cited by this paper
• Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

  1998cited by this paper
• A user's guide to the General Health Questionnaire

  1988cited by this paper

• Self-perceived cognitive impairment in the first year after breast cancer and the identification of at-risk patients.

  2024cites this paper
• Relationship of physical activity and cognitive functioning among breast cancer survivors: a cross-sectional analysis

  2024cites this paper
• Are there sustained psychological impacts in women diagnosed with in-situ or early invasive breast cancers?

  2023cites this paper
• Subchronic exposure to Tamoxifen modulates the hippocampal BDNF/ERK/Akt/CREB pathway and impairs memory in intact female rats.

  2023cites this paper
• Systematic review of longitudinal studies on chemotherapy‐associated subjective cognitive impairment in cancer patients

  2020cites this paper
• Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy

  2020cites this paper
• Late side effects of adjuvant treatment in patients with breast cancer

  2019cites this paper
• Cognitive Decline Secondary to Therapeutic Brain Radiation—Similarities and Differences to Traumatic Brain Injury

  2019cites this paper
• Specific Cancer Diseases: The Psychological Perspective

  2019cites this paper
• Exercise: A positive feature on functioning in daily life during cancer treatment - Experiences from the Phys-Can study.

  2019influential citation
• Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis

  2018cites this paper
• RETRACTED ARTICLE: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis

  2018cites this paper
• THE CREATIVE PSYCHOSOCIAL GENOMIC HEALING EXPERIENCE (CPGHE) AND GENE EXPRESSION IN BREAST CANCER PATIENTS: A FEASIBILITY STUDY.

  2018cites this paper